These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23958318)

  • 1. Insulin-like growth factor-I aerosol formulations for pulmonary delivery.
    Germershaus O; Schultz I; Lühmann T; Beck-Broichsitter M; Högger P; Meinel L
    Eur J Pharm Biopharm; 2013 Sep; 85(1):61-8. PubMed ID: 23958318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
    Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
    Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
    J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep.
    Luginbuehl V; Zoidis E; Meinel L; von Rechenberg B; Gander B; Merkle HP
    Eur J Pharm Biopharm; 2013 Sep; 85(1):99-106. PubMed ID: 23958321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
    Cipolla D; Wu H; Gonda I; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing protein formulations during air-jet nebulization.
    Albasarah YY; Somavarapu S; Taylor KM
    Int J Pharm; 2010 Dec; 402(1-2):140-5. PubMed ID: 20933073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of excipients on the stability and aerosol performance of nebulized aviscumine.
    Steckel H; Eskandar F; Witthohn K
    J Aerosol Med; 2003; 16(4):417-32. PubMed ID: 14977432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
    Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
    Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.